After reading the linked article below, I am concerned that ARNA's drug might not be recommended for approval.
http://blogs.forbes.com/matthewherper/2010/08/20/the-fdas-new-power/?partner=yahootix
I have sold my ARNA position (at $6.81, 8/24/2010). I currently hold VVUS and am awaiting any new information from the full FDA regarding their Qnexa drug.
No comments:
Post a Comment